1.THE RELATION BETWEEN THE ADRENAL AND THE GROWTH OF SARCOMA 180
Qixing ZHANG ; Jingya TONG ; Fangwen XU
Acta Anatomica Sinica 1957;0(04):-
The purpose of our studies was to investigate the relation between the condition of the adrenal and the growth of Sarcoma 180 (S_(180)) in mice. The hybrid Swiss mice were used and divided into four groups: (1) the normal mice for control, male and female, each one half, (2) testectomized mice, (3) female mice with natural resistance to S_(180), (4) S_(180)-bearing mice. The tissue slices of adrenal were stained with H. E. method. The adranal cortex was subdivided into eight zones according as I. C. Jones' opinion. The area of each zone in the cortex was measured by microscope and the weight of each adrenal was obtained with the 10~(-4) scales. The results of our studies are explained as follows:1. When the body weight of the normal adult mice increased, the adrenal weight did not increase. But there was obvious difference of adrenal weights between the normal adult male and female, the former was smaller and the later was larger.2. After S_(180) was implanted into the mice, the adrenal weight rapidly and markedly increased with the growth of S_(180) (P
2.An intervention study on the effects of vitamin D 3 on cognitive function and blood inflammatory cytokines in patients with Alzheimer's disease
Jingya JIA ; Ying XIONG ; Chong CHEN ; Keran DUAN ; Tong YANG ; Hualou WANG ; Fei MA
Chinese Journal of Geriatrics 2021;40(11):1357-1362
Objective:To assess the effects of a 12-month vitamin D 3 intervention on cognitive function and blood inflammatory cytokines in subjects with Alzheimer's disease(AD). Methods:Two hundred and ten AD patients were randomly divided into the intervention and control groups, with 105 patients in each group.The intervention group received vitamin D 3 800 U/day and the control group received a placebo for 12 months.Repeated-measures analysis of variance was used to evaluate the effects of vitamin D and placebo on cognitive performance and blood inflammatory cytokines at baseline, month 6 and month 12. Results:During the follow-up, serum 25(OH)D 3( F=712.086, P<0.001)and 1, 25(OH) 2D 3( F=372.038, P<0.001)concentrations in the intervention group were significantly higher than those in the control group.Changes in FSIQ, VIQ and PIQ between the groups, between different time points and with interaction between the variables taken into account were statistically significant(all P<0.001). Compared with the control group, interleukin-6(IL-6)( F=341.344, P<0.001)and tumor necrosis factor-α(TNF-α)( F=9.580, P<0.001)levels in the intervention group were significantly decreased, and the ratio of Aβ40 to Aβ42 was increased( F=4.617, P=0.010). There were interaction effects between group and time.Except for intervention effects, the baseline concentration of 25(OH)D 3 was positively correlated with scores of FSIQ( β=0.016, P=0.031)and VIQ( β=0.017, P=0.031). Conclusions:Daily oral vitamin D 3 supplementation(800 U/day)for 12 months may improve cognitive function and change inflammatory cytokines in elderly patients with AD.
3.New definition of metabolic dysfunction-associated fatty liver disease with elevated brachial-ankle pulse wave velocity and albuminuria: a prospective cohort study.
Jialu WANG ; Shanshan LIU ; Qiuyu CAO ; Shujing WU ; Jingya NIU ; Ruizhi ZHENG ; Lizhan BIE ; Zhuojun XIN ; Yuanyue ZHU ; Shuangyuan WANG ; Hong LIN ; Tiange WANG ; Min XU ; Jieli LU ; Yuhong CHEN ; Yiping XU ; Weiqing WANG ; Guang NING ; Yu XU ; Mian LI ; Yufang BI ; Zhiyun ZHAO
Frontiers of Medicine 2022;16(5):714-722
A new definition of metabolic dysfunction-associated fatty liver disease (MAFLD) has recently been proposed. We aim to examine the associations of MAFLD, particularly its discordance from non-alcoholic fatty liver disease (NAFLD), with the progression of elevated brachial-ankle pulse wave velocity (baPWV) and albuminuria in a community-based study sample in Shanghai, China. After 4.3 years of follow-up, 778 participants developed elevated baPWV and 499 developed albuminuria. In comparison with the non-MAFLD group, the multivariable adjusted odds ratio (OR) of MAFLD group for new-onset elevated baPWV was 1.25 (95% confidence interval (CI) 1.01-1.55) and 1.35 (95% CI 1.07-1.70) for albuminuria. Participants without NAFLD but diagnosed according to MAFLD definition were associated with higher risk of incident albuminuria (OR 1.77; 95% CI 1.07-2.94). Patients with MAFLD with high value of hepamet fibrosis score or poor-controlled diabetes had higher risk of elevated baPWV or albuminuria. In conclusion, MAFLD was associated with new-onset elevated baPWV and albuminuria independently of body mass index, waist circumference, and hip circumference. Individuals without NAFLD but diagnosed as MAFLD had high risk of albuminuria, supporting that MAFLD criteria would be practical for the evaluation of long-term risk of subclinical atherosclerosis among fatty liver patients.
Humans
;
Pulse Wave Analysis
;
Albuminuria
;
Ankle Brachial Index
;
Non-alcoholic Fatty Liver Disease/diagnosis*
;
Vascular Stiffness
;
Prospective Studies
;
Risk Factors
;
China/epidemiology*